Carriers of the aspartylglucosaminuria genetic mutation and chronic arthritis

Annals of the Rheumatic Diseases

Volumn 61, Issue 2, 2002, Pages 180-181

  Arvio, M ^a   Laiho, K ^b   Kauppi, M ^b   Peippo, M ^c   Leino, P ^d   Kautiainen, H ^b   Kaipiainen Seppanen O ^d   Mononen, I ^e  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

^b RHEUMATISM FOUNDATION HOSPITAL   (Finland)

^c Vaestoliitto   (Finland)

^d KUOPIO UNIVERSITY HOSPITAL   (Finland)

^e TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

RHEUMATOID FACTOR;

ADOLESCENT; ADULT; AGED; ARTICLE; ASPARTYLGLYCOSAMINURIA; AUTOSOMAL RECESSIVE DISORDER; CHRONIC ARTHRITIS; DNA DETERMINATION; FEMALE; GENE MUTATION; GENETIC PREDISPOSITION; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; PARENT; PRIORITY JOURNAL; QUESTIONNAIRE; RHEUMATOID ARTHRITIS; SYMPTOMATOLOGY;

ADULT; AGED; ARTHRITIS, RHEUMATOID; ASPARTYLGLUCOSYLAMINASE; CHRONIC DISEASE; FEMALE; GENES, RECESSIVE; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE; HUMANS; MALE; METABOLISM, INBORN ERRORS; MIDDLE AGED; MUTATION; RHEUMATOID FACTOR;

EID: 0036151116     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.61.2.180     Document Type: Article

References (14)

1. Aspartylglucosaminuria in the Finnish population: Identification of two point mutations in the heavy chain of glycoasporaginase
2. Follow-up in patients with aspartylglucosaminuria. Part I. The course of intellectual functions
3. Chronic arthritis in patients with aspartylglucosaminuria
4. DNA-based carrier screening in primary healthcare: Screening for ospartylglucosaminuria mutations in maternity health offices
5. Prospects of carrier screening of aspartylglucosaminuria in Finland
6. Finnish-type aspartylglucosaminuria detected by oligonucleotide ligation assay
7. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
8. Enzymatic diagnosis of aspartylglycosaminuria by fluorometric assay of glycosylasparaginase activity in serum, plasma or lymphocytes
9. Aspartylglucosaminuria: Deficiency of aspartylglucosaminidase in cultured fibroblasts of patients and their heterozygous parents
10. Incidence of chronic inflammatory joint diseases in Finland in 1995
11. The ARA 1987 revised criteria select patients with clinical arthritis from population based cohort of subjects with chronic rheumatic diseases registered for drug reimbursement
12. Incidence and prevalence of ankylosing spondylitis in Finland
13. Marker antibodies of rheumatoid arthritis: Diagnostic and pathogenetic implications